Loading...
Uploaded by medvidblog on Nov 11, 2008
In this video commentary, Dr. Black discusses TRANSCEND, a follow-on subset of ONTARGET, and PROFESS, for secondary stroke prevention -- both trials testing the ARB telmisartan on a randomized basis.
People & Blogs
Standard YouTube License
Load more suggestions
Link to this comment:
All Comments (0)